Shipment insurance

Aurora Cannabis delivers $8 million worth of cannabis to Israel

The shipment is part of the company’s strategy to advance its leadership in the global cannabinoid space


EDMONTON, Alta., July 15, 2021 /PRNewswire/ – Aurora Cannabis Inc. (the “Company” or “Aurora”) (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids around the world, today announced the delivery of ‘a shipment of cannabis worth almost 8 million Canadian dollarsin one of the largest shipments of cannabis that Israel has received.

The sale is an important step in advancing the company’s international medical business, a key strategic priority for Aurora as a global cannabis company. With leadership in both Canada and EuropeAurora is uniquely positioned to be a partner of choice in countries like Israelwhere recreational THC markets should be around the corner, and non-THC cannabinoids, such as CBD, are moving towards legalization.

“We are excited about the evolution of the cannabis industry in Israel and commend the Ministry of Health and the Israel Medical Cannabis Agency for ensuring thoughtful regulation of cannabis, in the best interests of Israeli patients who use cannabis,” says Michael Martin, CEO of Aurora. “We look forward to continuing to provide high quality cannabis to Israelas part of our strategy to expand our medical cannabis portfolio in key international markets. »

The Company, which has entered into a strategic supply agreement with Cantek Global Ltd., one of Israel’s leaders in the field of medical cannabis, intends to supply a minimum of 4,000 kg of dried flowers in bulk per year to Israel.

About Aurora

Aurora is a global cannabis industry leader serving the medical and consumer markets. Based at Edmonton, AB, Aurora is a global cannabis pioneer dedicated to helping people improve their lives. The Company’s brand portfolio includes Aurora, Aurora Drift, San Rafael ’71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler and Reliva CBD. Driven by science and innovation and focused on high quality cannabis products, Aurora’s brands continue to stand out as industry leaders in the medical, performance, well-being and leisure, wherever they are launched. For more information, please visit our website at

Aurora’s common shares trade on the TSX and NASDAQ under the symbol “ACB” and are included in the S&P/TSX Composite Index.

Forward-looking statements

This press release contains statements containing certain “forward-looking information” within the meaning of applicable securities laws (“forward-looking statements”). Forward-looking statements are often characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur. Forward-looking statements made in this press release include statements regarding the Company’s continued supply of cannabis to Israel and the quantity of cannabis to be supplied to Israel. These forward-looking statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this press release. Forward-looking statements are based on management’s opinions, estimates and assumptions in light of management’s experience and understanding of historical trends, current conditions and expected developments as of the date the statements are made. are doing, such as current and future market conditions, the ability to maintain selling and administrative expenses in line with current expectations, the ability to generate high-margin revenues in the Canadian consumer market, the regulatory environment current and future and future approvals and permits. Forward-looking statements are subject to a variety of risks, uncertainties and other factors that management believes are relevant and reasonable under the circumstances and which could cause events, results, level of activity, performance , the actual prospects, opportunities or achievements differ materially from those projected in the forward-looking statements, including risks associated with: entry into the United States market, the ability to realize the anticipated benefits associated with the acquisition of Reliva, the achievement of Aurora’s business transformation plan, general business and economic conditions, changes in laws and regulations, product demand, price changes of required commodities, competition, effects and responses to the COVID-19 pandemic and other risks, uncertainties and factors set forth under “Risk Factors” in the Annual Information Form e of the Company dated September 24, 2020 (the “Annual Information Form”) and filed with the Canadian securities authorities available on the Company’s issuer profile on SEDAR at and filed with and available on the SEC’s website at www. The Company warns that the list of risks, uncertainties and other factors described in the annual information form is not exhaustive and that other factors could also have an adverse effect on its results. Readers are urged to carefully consider the risks, uncertainties and assumptions when evaluating forward-looking statements and are cautioned not to place undue reliance on such information. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as expressly required. by applicable securities laws.

SOURCEAurora Cannabis Inc.

Related links